Lakshmikumaran and Sridharan logo

Articles

RBI 2

RBI Trade Regulations 2026: Key Reforms in Payment Timelines, Realisation & Reporting

Cross-border trade plays a vital role in boosting a country’s economic growth. With accelerated globalization, we have observed India emerging as one of the major players in the global supply chain. In the past decade, there has been a substantial rise in cross-border transactions; both in terms of volume and value and this rise has revealed various statutory hurdles in the extant applicable laws governing cross-border trade.

Asish Philip Abraham+223 Sept 2026
FUND

IFSCA mandates FMEs to maintain a website or webpage

The article discusses the recent circular which is issued by International Finance Services Centres Authority (‘IFSCA’) for imposing an obligation on Authorised FMEs, registered FMEs (Non-Retail) and Registered FMEs (Retail) to maintain a website or a webpage dedicated to their fund management activities in the IFSC.

Vinod Joseph21 Sept 2026
C

EPF Scheme, 2026 and International Workers: New framework – Old questions

The notification of the Employees' Provident Funds Scheme, 2026 (‘2026 Scheme’) with effect from 1 July 2026, was anticipated to settle and provide clarity on the regulatory framework governing international workers under the Code on Social Security, 2020. However, it has done the opposite in one respect. The 2026 Scheme retains a dedicated framework for international workers and carries forward the substance of the erstwhile Paragraph 83 of the EPF Scheme, 1952 (‘1952 Scheme’) and Paragraph 43A of the EPS, 1995.

Asish Philip Abraham+218 Sept 2026

Search Articles

  • Disclaimers – A credible way of amendment in patent claims and specification

    One of the permissible ways of amendments to claims and/or specification is to incorporate suitable disclaimers during the patent prosecution and at the post grant stage. The article aims to bring down the perspectives of the use of disclaimers as a provision to amend claims and/or specification. It focusses on provisions available under Section 59 of the Patents Act, 1970 and a glimpse on such provisions in major jurisdictions such as US and EU that are of greater interest.

    Srinivasan T.15 Mar 2024
  • Decoding Fiduciaries and Processors: The DPDPA lens

    The article dives deep into the understanding of certain key actors engaged in the processing of personal data – Data Fiduciaries and Data Processors. Observing that while Fiduciaries, by their nature, are expected to exercise decisional control over the purposes and means of processing, and Processors act on the former’s instructions, the article outline various complex situations where the roles blur.

    Sameer Avasarala04 Mar 2024
  • The WTO’s 13th Ministerial Conference – Finding Order in times of chaos?

    This article intends to provide an overview of some of the key issues for negotiation at MC 13 and the importance of these issues for WTO Members. It talks about Agreement on Investment Facilitation and Development, Agreement on Fisheries Subsidies, Permanent Solution for Public Stockholding for Food Security Purposes, WTO Dispute Settlement Reform, and Electronic Commerce.

    01 Mar 2024
  • Secondment or employment: Court’s observation opens new opportunities for tax risk mitigation in 2024

    The article discusses the observation of the Supreme Court in Northern Operating Systems case, recent investigations on the issue, CBIC Instruction, interim orders passed by different High Courts on factual matrix of the cases, legal position under the GST law and the way forward. Elaborating on the test / factors to determine the employee-employer relationship, the article deliberates on application of said tests/factors on the Supreme Court decision, and the factual differentiation of case.

    29 Feb 2024
  • The Ibrutinib saga

    The article discusses the recent decision of Single Judge of the Delhi High Court adjudicating a batch of suits filed by Pharmacyclics LLC and Johnson and Johnson Pvt. Ltd., pertaining to the infringement of Indian Patent 262968 against Hetero Labs, Natco Pharma, BDR Pharma, Alkem Labs and Shilpa Medicare for manufacturing and marketing Ibrutinib. The Court restrained the Defendants in all suits from manufacturing and marketing Ibrutinib, pending final disposal of the suits.

    28 Feb 2024
  • Keywords as trademarks not a source identifier

    The article discusses the recent judgment of the Delhi High Court in the case of MakeMyTrip India Pvt. Ltd, Booking Netherlands & Booking India and Google LLC in which the court reiterated that use of trademark as key words of search engines displays of someone else advertisement, absent any confusion or unfair advantage, would not infringe the trademark.

    27 Feb 2024
  • Personality Rights: Protection under IP laws

    There are two discernible facets when a celebrity wants to protect their personality rights: first, the right to protect one’s image from being commercially exploited without permission by treating it as a tort of passing off and second, the right to privacy which entails one’s right to be left alone. Analysing jurisprudential development in US and UK, the article elaborately summarises many case law governing jurisprudence in India on IP laws.

    Kriti Sood+115 Feb 2024
  • Trademark tangle: Deepika Padukone’s beauty brand dances through the tunes of ‘use in a trademark sense’ v. ‘descriptive use’

    A recent order passed by the Delhi High Court in favour of DPKA Universal Consumer Venture, rejecting the plea of interim injunction by Lotus Herbals against the former’s use of ‘Lotus Splash’, has garnered a lot of attention. The decision discusses the question of infringement, with specific reference to Section 30(2)(a) of the Trade Marks Act, 1999. The article discusses this interim order and analyses the jurisprudence on Section 30(2)(a).

    Vindhya S. Mani+215 Feb 2024
  • Audi alteram partem

    The Article discuss the Delhi High Court decision in the matter of Novartis AG v. Natco Pharma & Anr. where the Court held that clear distinction between the examination and the opposition process of patents is essential, and merging these distinct processes would render the entire system unwieldy and counterproductive. The High Court was deliberating on the question as to whether the opponent has a right to be heard..

    Vindhya S. Mani+114 Feb 2024
  • Adjudication of penalties by Registrar of Companies: Scope and its ambit

    The article discusses a recent decision of the RoC, NCT, adjudicating penalty for violation under Section 89 (Declaration in respect of Beneficial Interest in any share) and Section 90 (Register of Significant Beneficial Owner in a company). Elaborately analysing the decision and its implications, the authors are of the view that the RoC has taken a stricter approach with respect to compliances...

    Noorul Hassan31 Jan 2024
  • Consent Managers under Digital Personal Data Protection Act – Bridging the gap between Data Principal and Data Fiduciary

    The article discusses the measures introduced under the Digital Personal Data Protection Act, 2023 (‘DPDP Act’) to address challenges around management of data principals’ consent. The authors note that it is important for entities offering consent management services to ensure that their activities do not fall within the ambit of data processing.

    Prashant Phillips30 Jan 2024